Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 202 results for "glenmark generics inc"

Glenmark ends 1% higher; gets FDA nod Potassium Chloride ER Tablets
India Infoline

Glenmark generic of K-Dur approved

MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has received final Food and Drug Administration approval for potassium chloride extended-release tablets. Glenmark said Wednesday that its potassium chloride ER tablets, which come in dosages of ... Chain Drug Review, 9 minutes ago

Intendis GMBH et al. v. Glenmark Pharms. Inc., USA

) (Circuit Judges Prost, Moore, and Taranto presiding; Opinion by Moore, J.) (Appeal from D. Del., Robinson, J.) Drug Product and Patent(s)-in-Suit: Finacea® (azelaic acid); U.S. Patent No. 6,534,070 (the 070 patent) Nature of the Case and ...
 JD Supra1 day ago CAFC Affirms Finacea Gel Infringement Under Doctrine Of Equivalents  Lexology2 months ago Federal Circuit Affirms Finacea Gel Infringement Under Doctrine of Equivalents  National Law Review2 months ago Intendis GmbH v. Glenmark Pharmaceuticals Inc., USA (Fed. Cir. 2016)  JD Supra2 months ago
India Infoline

Glenmark raises $200 mn in bonds and other top pharma news

Reliance Life Sciences, the biopharmaceutical unit of Reliance Industries, has acquired the global rights for biosimilars, or copies, of infliximab from Boston-based Epirus Biopharmaceuticals. Infliximab is used to treat a broad range of medical ...
 India Infoline2 days ago Lupin launches generic oral contraceptive tablets in US and other top pharma news  India Infoline1 week ago Glenmark Pharma working on proprietary product rollout and other top pharma news  India Infoline1 week ago Ajanta Pharma launches ulcer drug and other top pharma news [India Infoline News Service]  Pharmacy Choice1 week ago
Times of India

Three cos get USFDA nod to launch drug of AstraZeneca

Mumbai: Aurobindo, Glenmark and Sun Pharma shares surged by up to 5% on Wednesday after the firms got US health regulator's nod to sell their generic versions of AstraZeneca's cholesterol drug Crestor in the American market. Aurobindo Pharma jumped ...
 Times of India1 week ago Sun, Glenmark, Aurobindo get USFDA nod for cholesterol drug  Chandigarh Tribune1 week ago Aurobindo, Glenmark jump on USFDA nod to antihyperlipidemic drug  Moneycontrol.com1 week ago
India Infoline

Buzzing stocks: Tata Motors cracks, Mphasis up, Glenmark Pharma drops

Check out the most important and latest stock news from NSE and BSE. Mphasis gained 1% to Rs.550. The company will announced its Q1 results on July 23. The company experienced a spurt in volumes by more than 1.08 times. Tata Motors plunged 12.5% ...
 India Infoline1 month ago Stock markets advance on pharma dose  The Freepress Journal1 week ago BSE: Top gainers and losers  Rediff.com1 week ago Sensex advances 128 points on pharma booster dose  Rediff.com1 week ago

Glenmark gets FDA final approval to sell anti-epileptic drug in US

USFDA has granted approval for the tablets in 200 and 400 milligram dosage forms Hyderabad: Glenmark Pharmaceuticals Ltd. on Thursday said it has received final approval to sell its anti-epileptic drug in the US, after a tentative approval received ...
 Livemint.com2 months ago

Digital Dose Inhaler Market to Reach $3.56 Billion by 2024: Grand View Research, Inc.

SAN FRANCISCO , July 27, 2016 /PRNewswire/ -- The global digital dose inhaler market is anticipated to reach a value of USD 3.56 billion by 2024, according to a new report by Grand View Research, Inc. The key factors contributing to the lucrative ...
 WorldNetDaily1 day ago
Times of India

REFILE-India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

* Dr Reddy's, Glenmark have invested heavily in Venezuela * India proposing to Caracas to make part of drug payments in oil * No agreement on barter deal yet, say Indian officials * Venezuela facing pressure to pay bills ...
 Reuters Africa2 months ago India eyes oil-for-drugs deal with Venezuela to recoup pharma cash  Sify2 months ago Oil-for-drugs deal likely with crisis-hit Venezuela  The Hindu2 months ago Indian pharma cos ready to accept oil instead of money from Venezuela  Times of India2 months ago

No Approval for Generic Product for Treatment of Rosacea **WEB ONLY**

Addressing infringement under the doctrine of equivalents and obviousness issues, the US Court of Appeals for the Federal Circuit affirmed the district court's ruling barring approval of a generic version of Finacea® gel until November 2018.
 JD Supra3 weeks ago

Glenmark's ANDA infringed Intraserv's skin medication patent

[Back To Home] [Back To Archives] From Intellectual Property Law Daily , May 16, 2016 By Mark Engstrom, J.D. A federal district court did not err in finding that Glenmark Pharmaceuticals infringed an Intraserv patent titled Composition with ...
 Wolters Kluwer Law & Business2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less